Trials / Completed
CompletedNCT01516229
Special Survey for Long Term Application
Specific Survey of Norditropin® in Achondroplasia: Survey for Long-term Application
- Status
- Completed
- Phase
- —
- Study type
- Observational
- Enrollment
- 395 (actual)
- Sponsor
- Novo Nordisk A/S · Industry
- Sex
- All
- Age
- 1 Year – 15 Years
- Healthy volunteers
- Not accepted
Summary
This study is conducted in Japan. The aim of this study is to assess the incidence rate of adverse drug reactions (ADRs) when using somatropin (Norditropin®) for treatment of for achondroplasia without epiphyseal line closure under normal clinical practice conditions.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | somatropin | Prescription of somatropin at the discretion of the physician |
Timeline
- Start date
- 1997-05-01
- Primary completion
- 2007-03-31
- Completion
- 2007-03-31
- First posted
- 2012-01-24
- Last updated
- 2017-02-27
Locations
2 sites across 1 country: Japan
Source: ClinicalTrials.gov record NCT01516229. Inclusion in this directory is not an endorsement.